Bio­gen, UCB step up to kick the tires at Acor­da as buy­out buzz grows — re­port

Acor­da $ACOR CEO Ron Co­hen ap­pears to have stirred up some high-lev­el in­ter­est in a po­ten­tial auc­tion.

Ru­mors have been swirling that days af­ter the biotech re­port­ed­ly brought in ad­vis­ers to help prep for a sale, some bid­ders have be­gun to step up to the ta­ble. And ear­ly Fri­day Bloomberg re­port­ed that Bio­gen and UCB have stepped up to kick the tires, along with pos­si­ble in­ter­est from Asian drug­mak­ers.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.